Quality of Life after Deep Brain Stimulation: A Primary versus Secondary Dystonia Comparative Study

20250 citationsJournal Article

Authors

Emily Sanrey · Surgimab (France)

Mariella Grasso · Surgimab (France)

Marie Brethome · Surgimab (France)

Emilie Chan‐Seng · Surgimab (France)

Valérie Gil · Surgimab (France)

Philippe Coubes · Surgimab (France)

Gaëtan Poulen ·

Abstract

QoL assessment, using a dedicated scale, was shown to complement BFMDRS, enhancing the detection of subtle symptom improvements in DBS-treated patients.

Topics & Keywords

Neurological disorders and treatments Parkinson's Disease Mechanisms and Treatments Botulinum Toxin and Related Neurological Disorders

UN Sustainable Development Goals

Reduced inequalities

Publication Details

Published in: Stereotactic and Functional Neurosurgery

Volume 103, Issue 3, pp. 206-211

DOI: 10.1159/000545755

Field-Weighted Citation Impact: 0.00